Stock Price Prediction

Analysis and Insights

Based on the analysis of news sentiment and technical indicators, here is the prediction for Becton Dickinson and Co (BDX) stock price for the next trading week:

News Sentiment and Fundamental Analysis:

• Positive News Sentiment: Becton Dickinson has received a high rating of 91% from Validea's P/E/Growth Investor model, indicating strong fundamentals and valuation in the Medical Equipment & Supplies industry. Additionally, the USMCA exemption announcement is seen as beneficial for BDX, as it has significant exposure to Mexico.

• Analyst Ratings: Wells Fargo has lowered the price target to $270 from $275 but maintains an Overweight rating, indicating confidence in the stock's performance. Barclays has also maintained a Buy rating with a price target of $278.

Technical Analysis:

• Current Price Action: BDX closed at $229.54 on March 7, 2025, with a 1.86% increase during the regular market session. The price is currently testing the Fibonacci resistance level of $230.72.

• Technical Indicators:

  • RSI: The Relative Strength Index (RSI) for BDX is at 50.12, indicating a neutral position.
  • MACD: The MACD line is slightly below the signal line, but the histogram is showing a potential bullish crossover.
  • Fibonacci Levels: The stock is approaching the first resistance level of $230.72, with a potential target of $233.59 if the resistance is broken.

Price Prediction:

Based on the combination of positive news sentiment, strong fundamentals, and technical indicators, the stock is expected to break through the resistance level and reach $233.59 in the next trading week.

Recommendation:

Buy BDX at the current price level of $229.54, with a target price of $233.59. The stock is expected to benefit from positive news sentiment and strong technical momentum.